Neurodawn Pharmaceutical Co., Ltd.

This early-phase study tests a new drug called RK-4 for people with a severe type of stroke (large hemispheric infarction) who cannot have standard clot-removal treatment. The drug is injected directly into the skull bone marrow once daily for three days. The main goals are to ch…

This early-stage study tests a new drug called Y-4 in 11 healthy adults to see how it moves through the body compared to pregabalin and riluzole. Participants take each drug once, and researchers measure drug levels and check for side effects. The goal is to gather information, n…